60 Participants Needed

Sleep Tests for Pediatric Sleep Apnea

(HOM-Kids Trial)

MA
YR
Overseen ByYaelis Roman-Rosado, BS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital of Philadelphia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Home sleep apnea test for pediatric sleep apnea?

Research shows that home sleep apnea tests (HSAT) are a good alternative to in-lab sleep studies for diagnosing obstructive sleep apnea in children, especially when they have a high chance of having the condition. These tests are more comfortable and cost-effective, and they have been found to be accurate in identifying sleep apnea.12345

Is home sleep apnea testing safe for children?

Home sleep apnea testing (HSAT) is generally considered safe for diagnosing sleep apnea in children, as it is a non-invasive procedure that can be done at home with telehealth support.23467

How is the home sleep apnea test (HSAT) treatment for pediatric sleep apnea different from other treatments?

The home sleep apnea test (HSAT) is unique because it allows children to be tested for sleep apnea in the comfort of their own home, with the support of telehealth or online video technicians, making it more convenient and less stressful compared to traditional in-lab polysomnography (PSG). This approach provides reliable results similar to in-lab tests, but with longer sleep times due to the familiar environment.238910

What is the purpose of this trial?

This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children

Research Team

CM

Christopher Cielo, MD

Principal Investigator

Children's Hospital of Philadelphia

Eligibility Criteria

This trial is for boys and girls aged 5-12 who have had surgery to remove their tonsils and adenoids (adenotonsillectomy) to treat sleep apnea. It's not for kids with a tracheostomy, those living without a parent in a facility, or those needing extra oxygen or air pressure during sleep.

Inclusion Criteria

I have had surgery to remove my tonsils and adenoids for sleep apnea.
I am a child aged between 5 and 12 years old.

Exclusion Criteria

I am a child living in a facility without my parent.
My child has a tracheostomy or a connection between the trachea and skin.
My child needs extra oxygen or help to breathe, especially during sleep.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo HSAT and PSG to evaluate OSA status following adenotonsillectomy

up to one month
2 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Home sleep apnea test
  • PSG
Trial Overview The study is checking if a home sleep apnea test (HSAT) can accurately tell if children still have obstructive sleep apnea after having their tonsils and adenoids removed, compared to the standard lab test called polysomnography (PSG).
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: HSAT prior to clinical sleep studyExperimental Treatment1 Intervention
Participants will be randomized to undergo HSAT before receiving their clinical, in-lab polysomnography
Group II: PSG first Participants will be randomActive Control1 Intervention
Participants will be randomized to undergo HSAT after receiving their clinical, in-lab polysomnography.

Home sleep apnea test is already approved in United States, European Union, Canada for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as Home Sleep Apnea Test for:
  • Diagnosis of obstructive sleep apnea (OSA)
  • Monitoring of OSA treatment effectiveness
πŸ‡ͺπŸ‡Ί
Approved in European Union as Home Sleep Apnea Test for:
  • Diagnosis of obstructive sleep apnea (OSA)
  • Monitoring of OSA treatment effectiveness
πŸ‡¨πŸ‡¦
Approved in Canada as Home Sleep Apnea Test for:
  • Diagnosis of obstructive sleep apnea (OSA)
  • Monitoring of OSA treatment effectiveness

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital of Philadelphia

Lead Sponsor

Trials
749
Recruited
11,400,000+

American Academy of Sleep Medicine

Collaborator

Trials
29
Recruited
3,000+

Findings from Research

Type IV portable monitors (PMs) show variable sensitivity (67.5-100%) and specificity (25-100%) for diagnosing obstructive sleep apnea (OSA) compared to the gold standard polysomnography (PSG), indicating that while they can be useful, their accuracy may not be reliable enough for standalone clinical use.
The review included 24 studies with 2068 patients, suggesting that while type IV PMs could improve access to OSA diagnosis, careful consideration of their diagnostic limitations is necessary to avoid potential misdiagnoses that could impact patient care.
Diagnostic accuracy of level IV portable sleep monitors versus polysomnography for obstructive sleep apnea: a systematic review and meta-analysis.Abrahamyan, L., Sahakyan, Y., Chung, S., et al.[2019]
A retrospective audit of 233 children aged 5-18 years showed that telehealth-supported home sleep apnea testing (HSAT) achieved a technical success rate of nearly 90%, indicating it is a reliable alternative for diagnosing pediatric obstructive sleep apnea (OSA).
The study found that 89.5% of patients obtained at least 6 hours of sleep during testing, and parental feedback indicated high satisfaction with the care and convenience of the telehealth service, suggesting strong family acceptability of this approach.
Telehealth-supported level 2 pediatric home polysomnography.Griffiths, A., Mukushi, A., Adams, AM.[2023]
The home sleep apnea test (HSAT) demonstrated a sensitivity of 71.43% and specificity of 95.83% for identifying moderate to severe obstructive sleep apnea in children, based on a study of 38 participants who underwent both HSAT and laboratory polysomnography.
The SHOOTS questionnaire, which assesses risk factors for sleep apnea, showed a sensitivity of 85.7% and specificity of 54.2% for identifying children at risk for obstructive sleep apnea, suggesting it could be a useful screening tool before conducting HSAT.
Clinical application of home sleep apnea testing in children: a prospective pilot study.Revana, A., Vecchio, J., Guffey, D., et al.[2023]

References

Diagnostic accuracy of level IV portable sleep monitors versus polysomnography for obstructive sleep apnea: a systematic review and meta-analysis. [2019]
Telehealth-supported level 2 pediatric home polysomnography. [2023]
Clinical application of home sleep apnea testing in children: a prospective pilot study. [2023]
Predictors of Obstructive Sleep Apnea on a Home Sleep Apnea Test After a Negative Attended Polysomnography. [2019]
Patient satisfaction with sleep study experience: findings from the Sleep Apnea Patient-Centered Outcomes Network. [2020]
Predictors of Obstructive Sleep Apnea on Polysomnography after a Technically Inadequate or Normal Home Sleep Test. [2018]
Differences between manual and automatic analysis in determining the severity of obstructive sleep apnea using home sleep apnea testing. [2019]
Comparing in-lab full polysomnography for diagnosing sleep apnea in children to home sleep apnea tests (HSAT) with an online video attending technician. [2022]
[Reliability of respiratory polygraphy for the diagnosis of sleep apnea-hypopnea syndrome in children]. [2008]
Two nights of home polysomnography in healthy 7-14-year-old children - Feasibility and intraindividual variability. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security